How much funding has Allay Therapeutics raised?

Allay Therapeutics has raised $133.5M in total funding, most recently a Series B round.

Who are Allay Therapeutics's investors?

Allay Therapeutics's investors include Arboretum Ventures, Lightstone Ventures, ClavystBio, NEA, Vertex Growth Fund, IPD Capital.

When was Allay Therapeutics founded?

Allay Therapeutics was founded in 2015.

Where is Allay Therapeutics headquartered?

Allay Therapeutics is headquartered in San Jose, California, United States.

What industry is Allay Therapeutics in?

Allay Therapeutics operates in Biotech, Pain Management, Healthcare, Medical Devices, Therapeutics.

How many employees does Allay Therapeutics have?

Allay Therapeutics has 11-50 employees.

Allay Therapeutics

Home • Allay Therapeutics

San Jose, United States · Founded 2015 · $133.5M raised

Pain Management

Headquarters: San Jose, California
Employees: 11–50
Founded: 2015
Business Model: B2B

Website: allaytx.com
Total Funding: $133.5M
Last Round: $16.0M Series BJun 2025
Rounds: 3

About

Allay Therapeutics is a clinical-stage biotechnology company pioneering ultra-sustained analgesic products to transform post-surgical pain management. Its lead program, ATX-101, uses extended-release local anesthetic formulations designed to provide long-lasting pain relief while reducing dependence on opioids. The company aims to expand the surgical pain management toolkit with safer, longer-lasting, and more tailored solutions.

Summary

Allay Therapeutics is a Biotech company based in San Jose, United States, founded in 2015. It has raised $133.5M in total across 3 rounds, most recently a $16.0M Series B round in Jun 2025. Investors include Arboretum Ventures, Lightstone Ventures and ClavystBio.

LinkedIn X (Twitter)